27 studies found for:    LY2216684
Show Display Options
Rank Status Study
1 Completed A Study to Evaluate the Effect of Genotype on LY2216684
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Quinidine
2 Completed A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Activated Charcoal
3 Completed A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Sertraline
4 Completed A Study to Evaluate the Effect of Food on LY2216684
Condition: Depressive Disorder, Major
Intervention: Drug: LY2216684
5 Completed A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Fluoxetine
6 Completed A Study to Evaluate the Effect of Clarithromycin on LY2216684
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Clarithromycin
7 Completed A Study of LY2216684 in Healthy Subjects
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: LY2216684 Placebo;   Drug: Alcohol Placebo containing beverage;   Drug: Alcohol containing beverage
8 Completed A Study of LY2216684 in Healthy Subjects Receiving Albuterol or Propanolol
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: albuterol;   Drug: propranolol;   Drug: placebo for LY2216684;   Drug: placebo for albuterol;   Drug: placebo for propranolol
9 Completed A Study of LY2216684 in Healthy Females
Condition: Depressive Disorder, Major
Interventions: Drug: LY2216684;   Drug: Ortho Cyclen;   Drug: Placebo
10 Completed A Study of LY2216684 and Theophylline in Healthy Subjects
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Theophylline
11 Completed A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo
12 Completed A Study of the Effect of LY2216684 on Lorazepam
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo;   Drug: Lorazepam
13 Completed A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel
Condition: Major Depressive Disorder
Interventions: Drug: Clopidogrel;   Drug: LY2216684 + clopidogrel
14 Completed A Study of LY2216684 and Digoxin in Healthy Subjects
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Digoxin
15 Completed A Study of LY2216684 and Warfarin in Healthy Subjects
Condition: Major Depressive Disorder
Interventions: Drug: Warfarin;   Drug: LY2216684
16 Completed A Study of LY2216684 in Subjects With Impaired Hepatic Function
Condition: Depressive Disorder, Major
Intervention: Drug: LY2216684
17 Completed A Study of LY2216684 in Patients With Major Depression Disorder
Condition: Major Depressive Disorder
Intervention: Drug: LY2216684
18 Active, not recruiting A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: LY2216684
19 Completed A Study in Prevention of Re-emergence of Depression Symptoms
Condition: Major Depressive Disorder
Interventions: Drug: LY2216684;   Drug: Placebo
20 Completed A Safety Study in Patients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Intervention: Drug: LY2216684

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
Indicates status has not been verified in more than two years